Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: A detailed cellular in situ hybridization study

Neuroscience

Volumn 72, Issue 4, 1996, Pages 1023-1036

  Augood, S J ^a   Faull, R L M ^b   Love, D R ^b   Emson, P C ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

basal ganglia; Huntington's disease; in situ hybridization; neuropeptide gene expression; striatal compartments

Indexed keywords

ENKEPHALIN; MESSENGER RNA; SUBSTANCE P;

ADULT; AGED; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GABAERGIC SYSTEM; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IN SITU HYBRIDIZATION; MALE; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PUTAMEN;

EID: 0029926199     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00595-1     Document Type: Article

References (51)

1. Albin R. L., Qin Y., Young A. B., Penney J. B. and Chesselet M.-F. (1991) Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study. Ann. Neurol. 30, 542-549.
2. Albin R. L., Reiner A., Anderson K. D., Dure L. S., Handelin B., Balfour R., Whetsell W. O., Penney J. B. and Young A. B. (1992) Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann. Neurol. 31, 425-130.
3. Albin R. L., Young A. B., Penney J. B., Balfour R., Anderson K. D., Markel D. S., Toutellote W. W. and Reiner A. (1990) Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. New Engl. J. Med. 322, 1293-1298.
4. Augood S. J., Arbuthnott G. W. and Emson P. C. (1995) Identified cholinergic neurones in the adult rat brain are enriched in GAP-43 mRNA: a double in situ hybridization study. J. chem. Neuroanat. 9, 17-26.
5. Augood S. J., Herbison A. E. and Emson P. C. (1995) Localization of GAT-1 GABA transporter mRNA in rat striatum: cellular co-expression with GAD-67 mRNA, GAD-67 immunoreactivity, and parvalbumin mRNA. J. Neurosci, 15, 865-874.
6. Besson M. J., Graybiel A. M. and Quinn B. (1990) Co-expression of neuropeptides in the cat's striatum: an immunohistochemical study of substance P, dynorphin B and enkephalin. Neuroscience 39, 33-58.
7. Bird E. D. and Iversen L. L. (1974) Huntington's chorea - post mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in the basal ganglia. Brain 97, 457-472.
8. Chesselet M.-F. and Affolter H.-U. (1987) Preprotachykinin messenger RNA detected by in situ hybridization in striatal neurons of the human brain. Brain Res. 410, 83-88.
9. DiFiglia M., Sapp E., Chase K., Schwarz C., Meloni A., Young C., Martin E., Vonsattel J.-P., Carraway R., Reeves S. A., Boyce F. B. and Aronin N. (1995) Huntington is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075-1081.
10. Dure L. S., Landwehrmeyer B. G., Golden J., McNeil S. M., Ge P., Aizawa H., Huang Q., Ambrose C. M., Duyao M. P., Bird E. D., DiFiglia M., Gusella J. F., MacDonald M. E., Penney J. B., Young A. B. and Vonsattel J.-P. (1994) IT15 gene expression in fetal human brain. Brain Res 659, 33-41.
11. Dure L. S., Young A. B. and Penney J. B. (1991) Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease. Ann. Neurol. 30, 785-793.
12. Emson P. C., Arregui A., Clement-Jones V., Sandberg B. E. B. and Rossor M. (1980) Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal and in Huntington's disease. Brain Res. 199, 147-160.
13. A-benzodiazepine receptors in the basal ganglia in Huntington's disease and in the quinolinic acid-lesioned rat. Prog. Brain Res. 99, 105-123.
14. Faull R. L. M., Waldvogel H. J., Nicholson L. F. B., Williams M. N. and Dragunow M. (1995) Huntington's disease and neural transplantation: GABA-A receptor changes in the basal ganglia in Huntington's disease in the human brain and in the quinolinic acid lesioned rat model of the disease following neuron transplants. In Neurotransmitters in the Human Brain (eds Tracey D. J., Stone J. and Paxinos G.), pp. 173-197. Plenum Press, New York.
15. Feger J. and Crossman A. R. (1984) Identification of different subpopulations of neostriatal neurons projecting to globus pallidus or substantia nigra in the monkey: a retrograde fluorescence double-labeling study. Neurosci. Lett. 49, 7-12.
16. Ferrante R. J., Kowall N. W., Richardson E. P., Bird E. D. and Martin J. B. (1986) Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum. Neurosci. Lett. 71, 283-288.
17. Folstein S., Abbott M. H., Chase G. A., Jensen B. A. and Folstein M. F. (1983) The association of affective disorder in Huntington's disease in a case series and in families. Psychol. Med. 13, 537-542.
18. Gerfen C. G. and Young W. S. III (1988) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460, 161-167.
19. Glass M., Faull R. L. M. and Dragunow M. (1993) Loss of cannabinoid receptors in the substantia nigra in Huntington's disease. Neuroscience 56, 523-527.
20. Goto S. and Hirano A. (1990) Synaptophysin expression in the striatum in Huntington's disease. Acta neuropath. 80, 88-91.
21. Goto S., Hirano A. and Rojas-Corona R. R. (1989) An immunohistochemical investigation of the human neostriatum in Huntington's disease. Ann. Neurol. 25, 298-304.
22. Graybiel A. M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13, 244-254.
23. Graybiel A. M. and Chesselet M.-F. (1984) Compartmental distribution of striatal cell bodies expressing [met]-enkephalin-like immunoreactivity. Proc. natn. Acad. Sci. U.S.A. 81, 7980-7984.
24. Harmar A. J., Armstrong A., Pascall J. C., Chapman K., Rosie R., Curtis A., Going J., Edwards C. R. W. and Fink G. (1986) cDNA sequence of human beta-preprotachykinin, the common precursor to substance-P and neurokinin-A. Fedn Eur. biochem. Socs Lett. 208, 67-72.
25. 2 receptor, proenkephalin A and substance P gene expression in the caudate nucleus of control and schizophrenic tissue: a quantitative cellular in situ hybridization study. Molec. Brain Res. 33, 333-342.
26. Hedreen J. C. and Folstein S. E. (1995) Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropath. exp. Neurol. 54, 105-120.
27. Herrero M.-T., Augood S. J., Hirsch E. C., Javoy-Agid F., Luquin M. R., Obeso J. A. and Emson P. C. (1995) Effects of L-DOPA on pre-proenkephalin and pre-protachykinin gene expression in the MPTP-treated monkey striatum. Neuroscience 68, 1189-1198.
28. Hoogeveen A. T., Willemsen R., Meyer N., de Rooij K. E., Roos R. A. C., van Ommen G.-J. B. and Galjaard H. (1993) Characterization and localization of the Huntington disease gene product. Human molec. Genet. 2, 2069-2073.
29. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
30. Hurd Y. L. and Herkenham M. (1993) Molecular alterations in the neostriatum of human cocaine addicts. Synapse 13, 357-369.
31. Hurd Y. L. and Herkenham M. (1995) The human neostriatum shows compartmentalization of neuropeptide gene expression in dorsal and ventral regions: an in situ hybridization histochemical analysis. Neuroscience 64, 571-586.
32. Kingsbury A. E., Foster O. J. F., Nisbet A. P., Cairns N., Bray L., Eve D. J., Lees A. J. and Marsden C. D. (1995) Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Molec. Brain Res. 28, 311-318.
33. Li S. H., Schilling G., Young W. S., Li X.-J., Margolis R. L., Stine O. C., Wagster M. V., Abbott M. H., Franz M. L., Ranen N. G., Folstein S. E., Hedreen J. C. and Ross C. A. (1993) Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11, 985-993.
34. Martin J. B. and Gusella J. F. (1986) Huntington's disease pathogenesis and management. New Engl. J. Med. 315, 1267-1278.
35. Morton A. J., Nicholson L. F. B. and Faull R. L. M. (1993) Compartmental loss of NADPH diaphorase in the neuropil of the human striatum in Huntington's disease. Neuroscience 53, 159-168.
36. Nisbet A. P., Foster O. J. F., Kingsbury A., Eve D. J., Daniel S. E., Marsden C. D. and Lees A. J. (1995) Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease. Neuroscience 66, 361-376.
37. Noda M., Teranishi Y., Takahashi H., Toyosato M., Notake M., Nakanishi S. and Numa S. (1982) Isolation and structural organization of the human preproenkephalin gene. Nature 297, 431-435.
38. Norris P. J., Waldvogel H. J., Faull R. L. M., Love D. R. and Emson P. C. (1996) Decreased neuronal nitric oxide synthase messenger RNA and immunoreactivity in the striatum of Huntington's disease. Neuroscience 72, 1037-1047.
39. Penney J. B. and Young A. B. (1983) Speculations on the functional anatomy of basal ganglia disorders. A. Rev. Neurosci. 6, 73-94.
40. Penney J. B. and Young A. B. (1986) Striatal inhomogeneities and basal ganglia function. Movement Disorders 1, 3-15.
41. Reiner A., Albin R. L., Anderson K. D., D'Amato C. J., Penney J. B. and Young A. B. (1988) Differential loss of striatal projection neurones in Huntington disease. Proc. natn. Acad. Sci. U.S.A. 85, 5733-5737.
42. Richfield E. K. and Herkenham M. (1994) Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Ann. Neurol. 36, 577-584.
43. Richfield E. K., Maguire-Zeiss K. A., Cox C., Gilmore J. and Voorn P. (1995) Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients. Ann. Neurol 37, 335-343.
44. Richfield E. K., O'Brien C. F., Eskin T. and Shoulson I. (1991) Heterogeneous dopamine receptor changes in early and late Huntington's disease. Neurosci. Lett. 132, 121-126.
45. Sapp E., Ge P., Aizawa H., Bird E., Penney J., Young A. B., Vonsattel J.-P. and DiFiglia M. (1995) Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis. Neuroscience 64, 397-404.
46. Selemon L. D. and Golman-Rakic P. S. (1990) Topographical intermingling of striatonigral and striatopallidal neurons in the Rhesus monkey. J. comp. Neurol. 297, 359-376.
47. Spokes E. G. S. (1980) Neurochemical alterations in Huntington's chorea. A study of post-mortem brain tissue. Brain 103, 179-210.
48. Strong T. V., Tagle D. A., Valdes J. M., Elmer L. W., Boehm K., Swaroop M., Kaatz K. W., Collins F. S. and Albin R. L. (1993) Widespread expression of the human and rat Huntington's disease gene in brain and non-neural tissues. Nature Genet. 5, 259-265.
49. Vonsattel J.-P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D. and Richardson E. P. Jr (1985) Neuropathological classification of Huntington's disease. J. Neuropath. exp. Neurol. 44, 559-577.
50. Warner J.-P., Barron L. H. and Brock D. J. H. (1993) A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Molec. cell Probes 7, 235-239.
51. Young W. S., Bonner T. I. and Brann M. R. (1986) Mesencephalic dopamine neurones regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. natn. Acad. Sci. U.S.A. 83, 9827-9831.